Nicholas Galakatos, 10% Owner at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 1,244,626 shares at $4.81 ($6.0M) on 2010-11-09, disclosed to the SEC on 2010-11-10.
Open-market sale of $6.0M AVNR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.10 | 44,626 | $228K | 3.8% |
| 2 | $4.81 | 1,200,000 | $5.8M | 96.2% |
| Total | $4.82 avg | 1,244,626 | $6.0M | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-12-14 | $193K | — | Filing → |